BEDFORD LABS: DOXORUBICIN HYDROCHLORIDE INJECT.
DOXORUBICIN HYDROCHLORIDE INJECT. Key specifications include physical_form: POWDER, administration: INTRAVENOUS, special_features: ISOTONIC; PRESERVATIVE FREE, primary_container_type: VIAL, SINGLE DOSE, supplementary_features: NOTE D: ANTINEOPLASTIC (CHEMOTHERAPY) DRUG, protective_storage_feature: ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-005-7327, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | INTRAVENOUS |
| special_features | ISOTONIC; PRESERVATIVE FREE |
| primary_container_type | VIAL, SINGLE DOSE |
| supplementary_features | NOTE D: ANTINEOPLASTIC (CHEMOTHERAPY) DRUG |
| protective_storage_feature | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 25.000 MILLILITERS |
| active_medicament_medicinal_strength | 2.000 MILLIGRAMS DOXORUBICIN HYDROCHLORIDE PER MILLILITER |
| part_name_assigned_by_controlling_agency | DOXORUBICIN HYDROCHLORIDE INJECTION USP 2MG/ML 25ML VIAL |
| NSN | 6505-01-005-7327 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.000 MILLIGRAMS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PHYSICAL FORM | POWDER |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | MITOMYCIN FOR INJECTION USP 5MG VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS MITOMYCIN ACTIVE INGREDIENT |